It includes structural modifications that enable GLP-1 receptor activation and a fatty acid moiety that extends its half-life to approximately five days, allowing once-weekly dosing
70% ,
Gastrointestinal Issues GI side effects are the most common, especially early on: Nausea Vomiting Diarrhea Constipation These may lessen over time but can persist in some patients, leading to dehydration and nutritional deficiencies
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
Two separate 20mg pens, even from the same supplier, carry the risk of minor lot-to-lot variation
#Healthcare #Biotech #Pharmaceuticals #Diabetes #Obesity #Innovation #ClinicalTrials To view or add a comment, sign in Anti-Obesity Drugs 1 Appetite Suppressants (Central Acting Agents) Mechanism: Reduce appetite Increase satiety Act on CNS (hypothalamus) Examples: Phentermine Phentermine + Topiramate Bupropion + Naltrexone 2 GLP-1 Receptor Agonists Mechanism: Increase insulin secretion Delay gastric emptying Promote satiety Examples: Liraglutide Semaglutide 3 Dual GIP & GLP-1 Agonist Example: Tirzepatide 4 Fat Absorption Inhibitors Mechanism: Inhibit pancreatic lipase Reduce dietary fat absorption Examples: Orlistat Cetilistat 5 Other / Adjunct Drugs Metformin (used in insulin resistance) Zonisamide (off-label) Therapeutic Effects Decrease appetite Increase fullness Reduce fat absorption Promote weight loss Improve metabolic parameters Important Note Lifestyle modification (diet + exercise) is essential along with medication
